These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8660201)
41. Randomized, non-inferiority trial comparing a nitric oxide releasing solution with a macrolide antibiotic for control of bovine respiratory disease in beef feedlot calves at high-risk of developing respiratory tract disease. Crepieux T; Miller C; Regev-Shoshani G; Schaefer A; Dorin C; Alexander T; Timsit E Res Vet Sci; 2016 Apr; 105():216-21. PubMed ID: 27033936 [TBL] [Abstract][Full Text] [Related]
42. Clinical efficacy of diclofenac sodium and flunixin meglumine as adjuncts to antibacterial treatment of respiratory disease of calves. Guzel M; Karakurum MC; Durgut R; Mamak N Aust Vet J; 2010 Jun; 88(6):236-9. PubMed ID: 20553574 [TBL] [Abstract][Full Text] [Related]
43. Effect of a new macrolide antibiotic (tilmicosin) on pneumonia experimentally induced in calves by Mycoplasma bovis and Pasteurella haemolytica. Gourlay RN; Thomas LH; Wyld SG; Smith CJ Res Vet Sci; 1989 Jul; 47(1):84-9. PubMed ID: 2772410 [TBL] [Abstract][Full Text] [Related]
44. Bovine respiratory syncytial virus in experimentally exposed and rechallenged calves; viral shedding related to clinical signs and the potential for transmission. Klem TB; Sjurseth SK; Sviland S; Gjerset B; Myrmel M; Stokstad M BMC Vet Res; 2019 May; 15(1):156. PubMed ID: 31109324 [TBL] [Abstract][Full Text] [Related]
45. Duration of immunity of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV, and BRSV in experimentally infected calves. Peters AR; Thevasagayam SJ; Wiseman A; Salt JS Prev Vet Med; 2004 Dec; 66(1-4):63-77. PubMed ID: 15579335 [TBL] [Abstract][Full Text] [Related]
46. Response to experimentally induced infection with bovine respiratory syncytial virus following intranasal vaccination of seropositive and seronegative calves. Ellis JA; Gow SP; Goji N J Am Vet Med Assoc; 2010 May; 236(9):991-9. PubMed ID: 20433400 [TBL] [Abstract][Full Text] [Related]
47. Efficacy of a saponin-adjuvanted inactivated respiratory syncytial virus vaccine in calves. Ellis JA; West KH; Waldner C; Rhodes C Can Vet J; 2005 Feb; 46(2):155-62. PubMed ID: 15825518 [TBL] [Abstract][Full Text] [Related]
48. Risk factors for epidemic respiratory disease in Norwegian cattle herds. Norström M; Skjerve E; Jarp J Prev Vet Med; 2000 Mar; 44(1-2):87-96. PubMed ID: 10727746 [TBL] [Abstract][Full Text] [Related]
49. Comparison of carprofen and flunixin meglumine as adjunctive therapy in bovine respiratory disease. Balmer TV; Williams P; Selman IE Vet J; 1997 Nov; 154(3):233-41. PubMed ID: 9414956 [TBL] [Abstract][Full Text] [Related]
50. Bovine viral diarrhea viral infections in feeder calves with respiratory disease: interactions with Pasteurella spp., parainfluenza-3 virus, and bovine respiratory syncytial virus. Fulton RW; Purdy CW; Confer AW; Saliki JT; Loan RW; Briggs RE; Burge LJ Can J Vet Res; 2000 Jul; 64(3):151-9. PubMed ID: 10935880 [TBL] [Abstract][Full Text] [Related]
51. Alternaria aerosol during a bovine respiratory syncytial virus infection alters the severity of subsequent re-infection and enhances IgE production. Kalina WV; Anderson ML; Gershwin LJ Comp Immunol Microbiol Infect Dis; 2006; 29(2-3):138-56. PubMed ID: 16644011 [TBL] [Abstract][Full Text] [Related]
52. Efficacy of tulathromycin compared with tilmicosin and florfenicol for the control of respiratory disease in cattle at high risk of developing bovine respiratory disease. Rooney KA; Nutsch RG; Skogerboe TL; Weigel DJ; Gajewski K; Kilgore WR Vet Ther; 2005; 6(2):154-66. PubMed ID: 16094563 [TBL] [Abstract][Full Text] [Related]
53. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration. Ellis J; Gow S; West K; Waldner C; Rhodes C; Mutwiri G; Rosenberg H J Am Vet Med Assoc; 2007 Jan; 230(2):233-43. PubMed ID: 17223757 [TBL] [Abstract][Full Text] [Related]
54. Effect of parenteral administration of erythromycin, tilmicosin, and tylosin on abomasal emptying rate in suckling calves. Nouri M; Constable PD Am J Vet Res; 2007 Dec; 68(12):1392-8. PubMed ID: 18052746 [TBL] [Abstract][Full Text] [Related]
55. The effect of streptomycin, oxytetracycline, tilmicosin and phenylbutazone on spermatogenesis in bulls. Barth AD; Wood MR Can Vet J; 1998 Feb; 39(2):103-6. PubMed ID: 10051958 [TBL] [Abstract][Full Text] [Related]
56. [Infection of cattle by bovine respiratory syncytial virus]. Maillard R Rev Prat; 2000 Feb; 50(4):356-8. PubMed ID: 10748665 [No Abstract] [Full Text] [Related]
57. Comparison of tilmicosin and cephapirin as therapeutics for Staphylococcus aureus mastitis at dry-off. Nickerson SC; Owens WE; Fox LK; Scheifinger CC; Shryock TR; Spike TE J Dairy Sci; 1999 Apr; 82(4):696-703. PubMed ID: 10212455 [TBL] [Abstract][Full Text] [Related]
58. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella spp. associated with bovine respiratory disease. Shryock TR; White DW; Staples JM; Werner CS J Vet Diagn Invest; 1996 Jul; 8(3):337-44. PubMed ID: 8844577 [TBL] [Abstract][Full Text] [Related]
59. Effect of infection with bovine respiratory syncytial virus on pulmonary clearance of an inhaled antigen in calves. Gershwin LJ; Gunther RA; Hornof WJ; Larson RF Am J Vet Res; 2008 Mar; 69(3):416-22. PubMed ID: 18312142 [TBL] [Abstract][Full Text] [Related]
60. Tilmicosin does not inhibit interleukin-8 gene expression in the bovine lung experimentally infected with Mannheimia (Pasteurella) haemolytica. Goubau S; Morck DW; Buret A Can J Vet Res; 2000 Oct; 64(4):238-42. PubMed ID: 11041503 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]